Jan 13 (Reuters) - Cardiome Pharma Corp COM.TO :
* Announces filing of marketing authorization application for intravenous
vernakalant in the Kingdom of Saudi Arabia
* Says Cardiome anticipates the authorization review to be completed in the
second half of 2017
* Source text for Eikon ID:nCNWKVbzCa
* Further company coverage COM.TO